457 related articles for article (PubMed ID: 18418773)
1. Alloreactivity of ex vivo-expanded T cells is correlated with expansion and CD4/CD8 ratio.
Mercier-Letondal P; Montcuquet N; Sauce D; Certoux JM; Jeanningros S; Ferrand C; Bonyhadi M; Tiberghien P; Robinet E
Cytotherapy; 2008; 10(3):275-88. PubMed ID: 18418773
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
3. T cells for suicide gene therapy: activation, functionality and clinical relevance.
Hollatz G; Grez M; Mastaglio S; Quaritsch R; Huenecke S; Ciceri F; Bonini C; Esser R; Klingebiel T; Kreuter J; Koehl U
J Immunol Methods; 2008 Feb; 331(1-2):69-81. PubMed ID: 18155021
[TBL] [Abstract][Full Text] [Related]
4. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
5. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G; He J; Zhang Z; Leventhal JR
Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.
Parmar S; Robinson SN; Komanduri K; St John L; Decker W; Xing D; Yang H; McMannis J; Champlin R; de Lima M; Molldrem J; Rieber A; Bonyhadi M; Berenson R; Shpall EJ
Cytotherapy; 2006; 8(2):149-57. PubMed ID: 16698688
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells.
Keever CA; Abu-Hajir M; Graf W; McFadden P; Prichard P; O'Brien J; Flomenberg N
Bone Marrow Transplant; 1995 Mar; 15(3):407-19. PubMed ID: 7599566
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and functional modulation of interleukin-2-activated peripheral blood mononuclear cells by anti-CD3 and anti-CD28 antibody.
Yoshino I; Yano T; Miyamoto M; Sugimachi K; Kimura G; Nomoto K
Lymphokine Cytokine Res; 1993 Aug; 12(4):191-6. PubMed ID: 8218591
[TBL] [Abstract][Full Text] [Related]
9. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells.
Lin SJ; Cheng PJ; Hsiao SS
Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741
[TBL] [Abstract][Full Text] [Related]
11. Retrovirus-mediated gene transfer in human primary T lymphocytes induces an activation- and transduction/selection-dependent TCR-B variable chain repertoire skewing of gene-modified cells.
Coito S; Sauce D; Duperrier A; Certoux JM; Bonyhadi M; Collette A; Kuehlcke K; Hervé P; Tiberghien P; Robinet E; Ferrand C
Stem Cells Dev; 2004 Feb; 13(1):71-81. PubMed ID: 15068695
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal T-cell activation protocol stimulates preferential expansion of EBV-specific T-cell clones in vitro.
Hedfors IA; Brinchmann JE
Cancer Immunol Immunother; 2004 May; 53(5):439-44. PubMed ID: 14624314
[TBL] [Abstract][Full Text] [Related]
13. The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.
Zappasodi R; Di Nicola M; Carlo-Stella C; Mortarini R; Molla A; Vegetti C; Albani S; Anichini A; Gianni AM
Haematologica; 2008 Oct; 93(10):1523-34. PubMed ID: 18728033
[TBL] [Abstract][Full Text] [Related]
14. TCR gene-engineered T cell: limited T cell activation and combined use of IL-15 and IL-21 ensure minimal differentiation and maximal antigen-specificity.
Pouw N; Treffers-Westerlaken E; Mondino A; Lamers C; Debets R
Mol Immunol; 2010 Apr; 47(7-8):1411-20. PubMed ID: 20303179
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel human thymocyte subset with a phenotype of CD3- CD4+ CD8 alpha + beta-1. Possible progeny of the CD3- CD4- CD8- subset.
Hori T; Cupp J; Wrighton N; Lee F; Spits H
J Immunol; 1991 Jun; 146(12):4078-84. PubMed ID: 1828260
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
[TBL] [Abstract][Full Text] [Related]
17. The frequency of regulatory CD3+CD8+CD28- CD25+ T lymphocytes in human peripheral blood increases with age.
Simone R; Zicca A; Saverino D
J Leukoc Biol; 2008 Dec; 84(6):1454-61. PubMed ID: 18780874
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of interleukin-5 production by CD4- CD8- (double-negative) T cells in lungs of both normal and congenitally athymic nude mice infected with Toxocara canis.
Takamoto M; Kusama Y; Takatsu K; Nariuchi H; Sugane K
Immunology; 1995 Jun; 85(2):285-91. PubMed ID: 7642218
[TBL] [Abstract][Full Text] [Related]
19. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
Yang SY; Rhee S; Welte K; Dupont B
J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
[TBL] [Abstract][Full Text] [Related]
20. A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets.
Watanabe M; Hara Y; Tanabe K; Toma H; Abe R
Int Immunol; 2005 Mar; 17(3):269-78. PubMed ID: 15668466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
